Actively Recruiting
A Prospective Cohort Study of IRPF in China
Led by Peking Union Medical College Hospital · Updated on 2020-03-18
500
Participants Needed
1
Research Sites
519 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a cohort study to investigate the disease course and treatment response of patients with idiopathic retroperitoneal fibrosis（IRPF）. Methods: All the patients fulfilling diagnostic criteria of IRPF would be enrolled around China. A online database system will been established. Endpoints: The primary endpoint is to investigate the clinical manifestations of Chinese IRPF patients; the secondary endpoints including the demographic features,laboratory characteristics, immunological tests, imaging and pathological features, in addition, the treatment and prognosis of the disease.
CONDITIONS
Official Title
A Prospective Cohort Study of IRPF in China
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male or female aged 18 to 75 years
- Signed informed consent to participate
- Diagnosed with definite or possible idiopathic retroperitoneal fibrosis (IRPF)
You will not qualify if you...
- Secondary forms of retroperitoneal fibrosis
- Pregnant women or females planning to bear a child soon
- Having severe, uncontrolled, or unstable diseases
- Having a malignancy or cancer
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Peking Union Medical College Hospital
Beijing, Beijing Municipality, China, 100032
Actively Recruiting
Research Team
Y
Yunyun Fei, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here